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The generation of induced pluripotent stem cells (iPSCs) presents a challenge to normal
developmental processes. The low efficiency and heterogeneity of most methods have
hindered understanding of the precise molecular mechanisms promoting, and roadblocks
preventing, efficient reprogramming. While several intermediate populations have been
described1-7, it has proved difficult to characterize the rare, asynchronous transition from
these intermediate stages to iPSCs. The rapid expansion of a minor population of
reprogrammed cells can also obscure investigation of relevant processes. Understanding of
the biological mechanisms essential for successful iPSC generation requires both accurate
capture of cells undergoing the reprogramming process and identification of the associated
global gene expression changes. Here we demonstrate that reprogramming follows an
orderly sequence of stage transitions marked by changes in cell surface markers CD44 and
ICAM1, and a Nanog-GFP reporter. RNA-sequencing (RNA-seq) analysis of these
populations demonstrates two waves of pluripotency gene up-regulation, and unexpectedly,
transient up-regulation of multiple epidermis-related genes, demonstrating that
reprogramming is not simply the reversal of normal developmental processes. This novel
high-resolution analysis enables the construction of a detailed reprogramming route map,
and this improved understanding of the reprogramming process will lead to novel
reprogramming strategies.
Several reports have suggested that reprogramming progresses in a somewhat ordered
manner3,5,6,8-10. In order to identify markers whose expression changed concurrent with
pluripotency gene expression we performed time course microarray analysis using a
piggyBac (PB) transposon-based secondary (2°) reprogramming system3,11 (Supplementary
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Figure 2a). Of a number of candidate cell surface markers, Cd44 and Icam1 demonstrated
the most dynamic expression changes throughout 2° MEF reprogramming (Supplementary
Figure 2b). For further investigation we generated an efficient 2° reprogramming system in
which doxycycline (dox) mediated induction of the reprogramming factors could be
monitored via an mOrange reporter placed after the 2A-peptide-linked reprogramming
cassette c-Myc-Klf4-Oct4-Sox2 (MKOS)12, and endogenous Nanog promoter activation
could be followed by expression of EGFP13 (Supplementary Figures 3,4). Reprogramming
cultures were supplemented with Vitamin C (VitC) and an Alk inhibitor (Alki) which
enhance reprogramming efficiency10,14,15. In this 2° reprogramming system, Nanog-GFP+
cells appeared as early as day 6, and >60% of mOrange+ transgene expressing cells were
found to be Nanog-GFP+ by day 12 (Supplementary Figure 5a). Most mOrange+ transgene
expressing cells lost Thy1 and gained E-cadherin expression by day4 (Supplementary
Figures 5b,c). SSEA-1 expression barely changed after day 8, with a gradual gain of Nanog-
GFP+ cells in both SSEA-1+ and SSEA-1− populations (Supplementary Figure 5d).
Consistent with heterogeneous expression of SSEA1 in iPSCs/ESCs, it was not possible to
accurately delineate the reprogramming process using SSEA-1 (Supplementary Figure 6). In
contrast, the appearance of CD44− and ICAM1+ cells at later time points closely correlated
with Nanog-GFP expression (Supplementary Figures 5e,f). Double staining for CD44 and
ICAM1 revealed that a distinct series of population changes occur during reprogramming
(Figure 1). Initially, MEFs displayed high CD44 and broad ICAM1 expression with the
majority becoming ICAM1− by day 6, along with the appearance of a minor CD44−
ICAM1− population. By day 8, CD44− populations appeared enriched, and at day 12 almost
all cells displayed an iPSC/ESC-like CD44− ICAM1+ profile, over 60% of which expressed
Nanog-GFP. Consistent with an observation that Nanog expression is not necessarily a sign
of completed reprogramming16, Nanog-GFP+ cells were observed even before cells obtained
this iPSC/ESC-like phenotype (CD44− ICAM1+). Both ICAM1+ and ICAM1− sorted MEF
demonstrated similar FACS profile changes during reprogramming (Supplementary Figure
7). Immunofluorescence for CD44 and ICAM1 revealed that reprogramming is not
synchronized even within individual colonies (Supplementary Figure 8). Secondary
reprogramming of non-polycistronic line 6c11,14 and primary reprogramming using MKOS
and OSKM20 PB transposons resulted in similar ICAM1/CD44 profile changes indicating
their sutability for use in other systems and contexts (Supplimentary Figure 9). These
findings demonstrated the asynchronous but stepwise manner of reprogramming and
highlighted the potential usefulness of CD44 and ICAM1 to isolate reprogramming
intermediate subpopulations.
Next, we aimed to confirm that the observed CD44/ICAM1 profile changes reflected the
transition of individual cells from one stage to the next, and not merely the loss of one major
population and expansion of another minor population. CD44+ ICAM1− (Gate1), CD44−
ICAM1− (Gate2) and CD44− ICAM1+ (Gate3) populations, either Nanog-GFP+ (NG+) or
Nanog-GFP− (NG−) were isolated by cell-sorting at day 10 of reprogramming and re-plated
in reprogramming conditions (Figure 2a). After 3 days both NG+ and NG− cells progressed
in the order of gates 1→2→3 (Figure 2b). This progression correlated well with increased
Nanog-GFP+ colony forming potential (cfp), with 3NG+ cells displaying similar
clonogenicity to fully reprogrammed iPSCs (Figure 2c). Of cells with the same CD44/
ICAM1 profile, Nanog-GFP expression correlated with a higher cfp (e.g. 1NG− vs 1NG+).
To more accurately examine the progression of the reprogramming process, cells from each
gate were sorted and their CD44/ICAM1/Nanog-GFP expression was re-analysed after 24
hours (Figure 2d). Based on total cell numbers in each gate after 24 hours (Supplementary
Figure 10), we generated a reprogramming route map representing differences in the
efficiency of these stage transitions and in Nanog-GFP+ cfp (Figure 2e). Similar results were
obtained when each subpopulation was sorted at day8 (Supplementary Figure 11). This
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analysis revealed that reaching a Nanog-GFP+ state is a rate limiting step – as few cells
overcame this barrier in the 24 hour assay – and those that do so reprogram more efficiently
than their Nanog-GFP− counterparts, consistent with the role of Nanog as an accelerator of
reprogramming and the gateway to pluripotency17,18.
To elucidate global gene expression changes during these stage transitions, we carried out
RNA-sequencing analysis using a highly multiplexed sample barcoding system19,20 (see
Methods Online, Supplementary Table 1). Hierarchical clustering using the complete list of
differentially expressed genes (DEGs) revealed four major branches; [MEFs], [1NG−/+ and
2NG−], [2NG−/+ and 3NG−/+], and [3NG+ sorted at day 15 (3NG+D15), iPSCs and ESCs]
(Figure 3a). These clusters correlate well with similarities in cfp of the respective
subpopulations (Figure 2c). There was a prominent gene expression difference between
3NG+ and 3NG+D15, with the latter being more similar to iPSCs and ESCs (Figure 3a,
Supplementary Figures 12a,c), possibly reflecting the observed difference in cfp in the
absence of dox (Supplementary Figure 13). The DEGs between these two populations may
be involved in the establishment of an exogenous factor independent self-renewal state.
Principal component analysis clearly distinguished 2NG+ from 3NG− cells, consistent with
the higher probability of the former to reach the 3NG+ state within 24 hours (Supplementary
Figures 11c and 12b). DEGs could be classified into five distinct expression pattern groups
(A to E) (Figure 3a, Supplementary Tables 2,3). Group A contained readily down-regulated
fibroblast-related genes. Group D comprised factors gradually up-regulated toward iPSCs,
where ESC genes were highly enriched (P≤0.000367) (Figure 3c). However Group C, which
contained genes up-regulated at early stages and maintained throughout reprogramming,
also included some pluripotency related factors. To extend this finding, we examined the
expression pattern of 22 pluripotency-related genes in our data set21,22. Interestingly, 8
pluripotency genes, including endogenous Oct4 (Pou5f1) were already up-regulated at the
1NG+/2NG− stages to the level found in 3NG+ cells (Figure 3b Early), while 14
pluripotency genes were more gradually up-regulated in the later stage reprogramming
populations (Figure 3b Late, Supplementary Table 4). This early and late pluripotency gene
up-regulation was confirmed at the single cell level5 (Figure 3e), highlighting the high
resolution of the CD44/ICAM1 sorting system.
We also identified two additional gene expression patterns displaying transient up-regulation
(Group B) or down-regulation (Group E) exclusively in the intermediate stages of
reprogramming. This finding indicates that reprogramming from MEFs to iPSCs is not
simply the loss of MEF genes and gain of ESC genes. Gene Ontology analysis revealed that
genes related to ectoderm/epidermis development and keratinocyte differentiation were
highly enriched in Group B (P≤0.000274) (Figures 3c,d, Supplementary Tables 3-5). While
Sfn and Krt17 were barely detectable by immunofluorscence in MEFs and iPSCs, transient
up-regulation was observed in the intermediate stages of reprogramming (Supplementary
Figure 14). Single cell PCR confirmed co-expression of epidermis genes (Ehf, Ovol1) with
early pluripotency genes in the 1NG−/+ stage (Figure 3e). Consistent with our data, analysis
of three published microarray data sets incorporating partially reprogrammed iPSCs
(piPSCs)1, a time course experiment3 and a subpopulation analysis with Thy1, SSEA-1 and
Oct4-GFP6 confirmed transient epidermal gene expression during reprogramming
(Supplementary Figures 15-17, Supplementary Tables 6-8). Partially reprogrammed cells
from B cells also displayed similar epidermis gene expression4, while Oct4, Sox2 two
factor-reprogramming of MEFs did not23. Therefore, this intermediate state could be a
consequence of the use of Klf4 which is important for efficient reprogramming and
demonstrates the reprogramming process is not simply reversion of normal differentiation
(Summarized in Supplementary Figure 1). It would be intriguing to investigate if similar
transient gene expression changes can be seen in reprogramming of ectoderm or endoderm
lineages. Down-regulation of these epidermis genes coincided with up-regulation of “late”
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pluripotency genes. Future examination of this rapid switch in gene expression may provide
a novel insight into the molecular mechanism of reprogramming.
The integrative data analysis described above demonstrated this CD44/ICAM1/Nanog-GFP
marker system, uniquely, could provide high-resolution information during late pluripotency
gene up-regulation enabling discrimination of ‘reprogramming’ from ‘expansion of
reprogrammed cells’ (Figure 3b, Supplementary Figures 16b, 17f,). This system also refines
investigation of the kinetics of reprogramming. It has recently been shown that VitC
increases reprogramming efficiency by facilitating H3K9 demethylation7 and that
reprogramming factors fail to bind trimethylated H3K9 rich regions in the initial stages of
reprogramming24. We carried out reprogramming in the absence of VitC and observed not
only a decrease in the iPSC colony number, but also a marked delay in the transition from
one stage of reprogramming to the next (Supplementary Figure 18). Similar analyses can be
performed using our marker system to investigate the mechanism of action of other factors
that alter reprogramming efficiency. Isolation and analysis of subpopulations affected by
these factors could reveal the downstream genes specifically involved in, and required for,
successful reprogramming. Further studies using this high resolution analysis system have




The piggyBac (PB) transposon PB-TAP containing the tetO2 promoter, an attR1R2 Gateway
cloning cassette (Invitrogen) and rabbit β-globin poly A signal, was provided by A. Nagy.
To minimize silencing of the reprogramming vector, a chicken β-globin insulator30, and a
human lamin B2 (LMB2) replicator31 were inserted in PacI site between PB 3′TR and the
tetO2, EcoRV site between rabbit β-globin poly A signal and PB 5′TR, respectively, to
generate PB-TAP IRI. The BamHI fragment containing loxP flanked MKOS reprogramming
cassette followed by ires-mOrange (2LMKOSimO) from pCAG2LMKOSimO12 were
inserted into a Gateway entry vector pENTR 2B (Life Technologies), to generate
attP2LMKOSimO pENTR. Finally the attP2LMKOSimO cassette was Gateway cloned into
the PB-TAP IRI to yield reprogramming PB transposon PB-TAP IRI attP2LMKOSimO.
Similarly, reprogramming PB transposon PB-TAP IRI 2LOSKMimO was generated after
transferring the OSKM reprogramming cassette32 into attP2LMKOSimO pENTR replacing
the MKOS cassette. Sequences of the plasmids are available upon request.
Generation of a primary iPSC line D6s4B5
12.5 d.p.c. embryos were obtained from Rosa-rtTA/rtAT, Nanog-GFP/+, Col1a1+/+ mice
which were derived by a crossing TNG mice13 and B6;129-Gt(ROSA)26Sortm1(rtTA*M2)Jae
Col1a1tm2(tetO-Pou5f1)Jae/J (The Jackson Laboratory). The embryos were decapitated,
eviscerated, dissociated with 0.25% trypsin, 0.1% EDTA and plated in MEF medium
(GMEM, 10% FBS, penicillin-streptomycin, 1× Non-Essential Amino Acids (Invitrogen), 1
mM Sodium Pyruvate, 0.05 mM 2-Mercaptoethanol ). The PB-TAP IRI attP2LMKOSimO
(500 ng) and pCyL43 PB transposase expression vector33 (2 μg) were introduced into the
MEFs via Nucleofection (Amaxa) as before11, and cells were cultured in the ES cell
medium (MEF medium supplemented with 1000 U ml−1 Leukemia inhibiting factor (LIF))
in the presence of 1.0 μ ml−1 doxycycline (dox) (Sigma) for an initial 8 days and thereafter
0.5 μg ml−1 dox. Pluripotency of a clonal iPSC line D6 was confirmed by teratoma
formation and a subclone D6s4B5 was used for secondary reprogramming. For comparing
CD44 and ICAM1 profiles of primary reprogramming with PB-TAP IRI attP2LMKOSimO
and PB-TAP IRI 2LOSKMimO vectors, MEF were nucleofected as above and cultured in
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the presence of 1.0 μ ml−1 dox, Vitamin C (10 μg ml−1) (Sigma) and Alk inhibitor (500 nM)
(A83-01, TOCRIS Bioscience).
Secondary reprogramming
Each chimeric embryo were harvested at 12.5 d.p.c., dissociated and cultured in MEF
medium. One twentieth of the dissociated cells were exposed to dox (300 ng ml−1) for 2
days and the proportion of transgenic (Tg) MEFs was measured by FACS analysis of
mOrange expression. For FACS time course and colony counting experiments secondary Tg
MEFs were diluted to 5% and 30% by addition of wild type 129 MEFs and plated in
gelatinized 6 well-plate at 1×105 cells per well (5,000 and 30,000 Tg MEFs per well,
respectively). For sorting experiments MEFs were plated at 2×105 cells per gelatinized 100
mm plate (1×104 Tg MEFs per plate). Cells were cultured in Reprogramming medium,
which is ES cell medium supplemented with dox (300 ng ml−1), Vitamin C (10 μg ml−1)
and Alki (500 nM). Medium was changed every 2 days.
Flow Cytometry and cell sorting
Surface marker analysis was performed with the following eBioscience antibodies
(catalogue number; dilution): CD54/ICAM-1-biotin (13-0541; 1/100), CD44-biotin
(17-0441; 1/100), CD44-APC (17-0441; 1/300), Streptavidin-PE-Cy7 (25-4317-82; 1/1500),
SSEA-1-647 (51-8813; 1/50), CD324/E-Cadherin-biotin (13-3249; 1/100), Thy1-APC
(17-0902, 1/300), CD2-biotin (13-0029; 1/100). For sorting experiments dead cells were
excluded using DAPI nucleic acid stain (Invitrogen) (0.5ng/mL). Cells were incubated in
0.25% Trypsin, 1mM EDTA (Life Technologies) for 1-2 minutes at 37°C, harvested in
GMEM containing 10% FCS and counted. Staining was carried out in FACS buffer (2%
FCS in PBS) at ~1×106 cells ml−1 for 15-30 min at 4°C, and which was followed by
washing with FACS buffer, sorting and/or analysis with FACSAriaII and LSRFortessa (both
BD Biosciences), respectively. Excitation laser lines and filters used for each fluorophore
are summarized in Supplementary Table 9. Data were analysed using FlowJo software (Tree
Star). Intact cells were identified based on forward and side light scatter, and subsequently,
analysed for fluorescence intensity. Additional gating was carried out as outlined in
Supplementary Figure 2. For colony formation assays, sorted cells were plated on γ-
irradiated MEFs in 12-well plates at 3.5×103 cells per well. Nanog-GFP+ colonies were
quantified 10 days post sort. For 24 hour or time course analysis, sorted cells were plated in
gelatinized 48-well plate at 1×104 cells per well. In both cases, cells were cultured in
Reprogramming medium after sort.
Immunofluorescence and confocal microscopy imaging
Images of cells stained with CD54/ICAM-1-biotin (1/100 dilution), CD44-APC (1/300
dilution) antibodies and Streptavidin-PE-Cy7 (1/1500 dilution) described above were
captured with a confocal microscope (Leica TSC SP2) and Leica confocal software. Cells
stained with anti-Krt17 (LifeSpan BioSciences), anti-Sfn (Sigma) antibodies and anti-Rabbit
IgG CF633 secondary antibody (Sigma) were imaged with a fluorescence microscopy
(Olympus).
Multiplexed RNA Sequencing and data analysis
RNA was isolated with TRI reagent (Sigma) following the manufacturer’s instructions.
RNA quality and concentration was determined using the Agilent 2100 Bioanalyzer (Agilent
Technologies). Using 10ng RNA, reverse transcription with barcoded primers, cDNA
amplification and sequencing with Illumina HiSeq 2000 was performed as previously
described19,20. Quality control of the obtained reads and alignment to the mouse reference
genome (NCBI37/mm9) was performed using the GeneProf web-based analysis suite with
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default parameters25. Gene expression read counts were exported and analysed in R to
identify differentially expressed genes (DEGs), using the edgeR and DESeq Bioconductor
libraries26-28. For both methods, low expression transcripts (less than 13 reads in all
samples) were filtered out and P-values were adjusted using a threshold for false discovery
rate (FDR) ≤ 0.05. Genes listed as DEGs by both methods in any two subpopulation
comparison indicated in Supplementary Figure 6a (total 3,171) were used for further
analysis. Hierarchical clustering and K-means clustering (K=5) was performed using Cluster
3.0 and Java Treeview was used for visualisation34,35. This multiplexed RNA-sequencing
technology reads only the 5′ end of transcript, thus detecting only endogenous Oct4 and
Sox2. Nanog expression was detectable in Nanog-GFP− populations due to the reporter
system. Principal Components Analysis (PCA) was performed in R and plotted with the
scatterplot3d library36. Gene ontology (GO) enrichment was calculated using the DAVID
functional annotation bioinformatics tool29. GO term enrichment analysis was carried out
with a modified Fisher Exact p-value. The three additional published studies1,3,6 (GEO
accession number GSE21757, GSE14012, GSE42379) were analysed in a similar way. For
the time course data the analysis was performed as following: data were RMA37 normalised
using the Expression Console from Affymetrix and, since no replicates were provided, fold
changes (FC) between each two samples were calculated in Excel. Genes with more than 1.5
FC were classified as DEGs. For the Plath and Polo dataset, data were RMA normalised
using the ‘affy’ package38 in R and DEGs were identified using the ‘limma’ package38 in R
with FC>=1.5 and FDR<=0.05 or FC>=1.5 where no replicates were available.
Subsequently, K-means clustering of the identified DEGs was performed for all studies.
Selected gene expression data shown as relative expression against the highest signal among
the samples using an averaged signal value (reads per million) of duplicates/triplicates.
Single-cell gene expression analysis
Single cell qPCR was performed as described previously5 with slight modifications. Briefly,
22 sets of TaqMan Gene Expression assays (Applied Biosystems, Supplementary Table 9)
were pooled at a final concentration of 180 nM per primer set and 50 μM per probe.
Individual cells were sorted directly into 10 μl RT-PreAmp Master Mix (5 μl of CellsDirect
Reaction Mix (Invitrogen), 2.5 μl of pooled assays, 0.2 μl of SuperScript III (Invitrogen),
1.3 μl of water) using FACSAria II. Cell lysis and sequence-specific reverse transcription
were performed at 50°C for 15 min. The reverse transcriptase was inactivated by heating to
95°C for 2 min. Subsequently, in the same tube, cDNA went through sequence-specific
amplification by denaturing at 95C for 15 s, and annealing and amplification at 60°C for 4
min for 22 cycles. Preamplified products were diluted 5-fold with water and analysed in
48.48 Dynamic Arrays on a BioMark System (Fluidigm) following the Fluidigm protocol.
Ct values were calculated and visualized using BioMark Real-time PCR Analysis software
(Fluidigm). Each assay was performed in replicate.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. FACS analysis during 2° reprogramming of MEF with CD44/ICAM1 double staining
Loss of CD44 expression was rapidly followed by ICAM1 upregulation and Nanog-GFP
expression. By day 12 the majority of cells displayed an ICAM+/CD44− ESC-like profile.
Red; Nanog-GFP− cells, Green; Nanog-GFP+ cells.
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Figure 2. CD44/ICAM1 subpopulations represent distinct stages of reprogramming
a. Nanog-GFP+ (NG+) and Nanog-GFP− (NG−) cells were subdivided into CD44+ ICAM1−
(Gate1), CD44− ICAM1− (Gate 2) and CD44− ICAM1+ (Gate 3) populations at day 10 of
reprogramming. b. FACS analysis of sorted subpopulations after 3 day culture in the
presence of dox. c. Relative probability to generate Nanog-GFP+ iPSC colonies from each
subpopulation compared to fully reprogrammed iPSCs. Error bars represent standard
deviation, n=3 d. CD44/ICAM1/Nanog-GFP expression was re-analysed 24 hours after
sorting. e. Major transitions (>500 cells) of each populationwithin 24 hours. Y axis indicates
relative colony formation potential after an additional 10 days. Arrow size reflects relative
cell numbers.
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Figure 3. Global gene expression changes during the stage transition
a. Hierarchical clustering of samples with DEGs and expression heat map. Groups A-E
represent different expression patterns. b. Early and late up-regulation of pluripotency-
related genes. Black and red asterisks indicate early and late pluripotency genes respectively
as previously identified by single cell qPCR5. c. Epidermis gene and stem cell gene
enrichment in gene list B and D respectively. d. Transient up-regulation of 18 epidermis/
keratinocyte-related genes during reprogramming. e. Single-cell gene expression analysis.
Each square represents one reaction chamber from one cell. Colour corresponds to ΔCT
value as shown in legend at right.
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